Earkart

Why is Earkart Limited falling/rising?

As of 17-Jul, Earkart Limited's stock price is stable at 160.00 with no change, but it has increased by 23.08% over the past month. Despite this growth, concerns arise from erratic trading and declining investor participation, suggesting a cautious outlook.

As of 17-Jul, Earkart Limited's stock price is currently stable at 160.00, showing no change (0.00%). Over the past week, the stock has not experienced any price movement, which is in contrast to the Sensex, which has risen by 0.75%. However, looking at the longer-term performance, Earkart Limited has seen a significant increase of 23.08% over the past month, while the Sensex has only increased by 1.29%. Year-to-date, the stock has risen by 7.53%, while the Sensex has declined by 8.30%.<BR><BR>Despite these positive trends, there are some concerning indicators. The stock has shown erratic trading, having not traded on 5 out of the last 20 days, and there has been a notable decline in investor participation, with delivery volume dropping by 68.75% compared to the 5-day average. Additionally, while the stock's price is above its 5-day, 20-day, 50-day, and 100-day moving averages, it remains below the 200-day moving average, which could indicate a potential weakness in the stock's performance.<BR><BR>Overall, while Earkart Limited has experienced a rise in its stock price over the month and year-to-date, the lack of trading activity and declining investor participation may contribute to a cautious outlook among investors.

Which are the latest news on Earkart?

What does Earkart do?

Earkart Limited is a micro-cap company in the healthcare services industry with no reported sales or profits for the latest quarter. It has a market cap of INR 164 Cr, a P/E ratio of 35.00, and a return on equity of 7.66%.

Overview: <BR>Earkart Limited operates in the healthcare services industry and is categorized as a micro-cap company.<BR><BR>History: <BR>No specific incorporation year or status changes are provided, and there are no reported sales or profits for the latest quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 164 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 35.00 <BR>Industry P/E: 92 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.34 <BR>Return on Equity (ROE): 7.66% <BR>Price-to-Book: 2.54<BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is Earkart?

As of 10th June, Earkart Limited has a market capitalization of 164.00 Cr, classifying it as a Micro Cap company. There is no available financial data for Net Sales and Net Profit for the latest four quarters.

As of 10th June, <BR><BR>Market Cap: Earkart Limited has a market capitalization of 164.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is for March 2025, with Shareholder's Funds amounting to 19.92 Cr and Total Assets totaling 30.19 Cr.

Who are the peers of the Earkart?

Earkart's peers include Hemant Surgical, Prevest Denpro, Take Solutions, Nureca, Star Imaging, Jeevan Scienti., Bilcare, Aspira Pathlab, QMS Medical, and Aakaar Medical. Hemant Surgical shows the highest 1-year return at 278.57%, while Prevest Denpro has the lowest at -22.92%.

Peers: The peers of Earkart are Hemant Surgical, Prevest Denpro, Take Solutions, Nureca, Star Imaging, Jeevan Scienti., Bilcare, Aspira Pathlab, QMS Medical, Aakaar Medical.<BR><BR>Quality Snapshot: Excellent management risk is observed at Prevest Denpro and Star Imaging, while Good management risk is found at Aakaar Medical and Hemant Surgical. Average management risk is noted at QMS Medical, while Below Average management risk is present at Take Solutions, Nureca, Jeevan Scienti., Bilcare, Aspira Pathlab. In terms of Growth, Good growth is seen at Hemant Surgical and Aakaar Medical, while Below Average growth is noted at Prevest Denpro, Take Solutions, Nureca, Star Imaging, Jeevan Scienti., Bilcare, Aspira Pathlab, and QMS Medical. Good capital structure is present at Prevest Denpro, Aakaar Medical, and Hemant Surgical, while Excellent capital structure is noted at Star Imaging. Average capital structure is found at Jeevan Scienti., QMS Medical, and Aspira Pathlab, while Below Average capital structure is observed at Take Solutions, Nureca, Bilcare.<BR><BR>Return Snapshot: Hemant Surgical has the highest 1-year return at 278.57%, while Prevest Denpro has the lowest at -22.92%, with Earkart's 1-year return being not applicable. Additionally, peers such as Nureca, Bilcare, and Prevest Denpro have negative six-month returns.

When is the next results date for Earkart Limited?

The next results date for Earkart Limited is 29 May 2026.

The next results date for Earkart Limited is scheduled for 29 May 2026.